Response to letter regarding article, "efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation"

Lars Wallentin, Renato D. Lopes, Michael Hanna, Laine Thomas, Anne Hellkamp, Sunil Nepal, Elaine M. Hylek, Sana M. Al-Khatib, John H. Alexander, Marco Alings, John Amerena, Jack Ansell, Philip Aylward, Jozef Bartunek, Patrick Commerford, Raffaele De Caterina, Cetin Erol, Veli Pekka Harjola, Claes Held, John HorowitzKurt Huber, Steen Husted, Matyas Keltai, Fernando Lanas, Liu Lisheng, John J.V. McMurray, Byung Hee Oh, Mårten Rosenqvist, Witold Ruzyllo, Philippe Gabriel Steg, Dragos Vinereanu, Denis Xavier, Christopher B. Granger

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)e21-e22
JournalCirculation
Volume129
Issue number2
DOIs
Publication statusPublished - Jan 14 2014

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Wallentin, L., Lopes, R. D., Hanna, M., Thomas, L., Hellkamp, A., Nepal, S., Hylek, E. M., Al-Khatib, S. M., Alexander, J. H., Alings, M., Amerena, J., Ansell, J., Aylward, P., Bartunek, J., Commerford, P., De Caterina, R., Erol, C., Harjola, V. P., Held, C., ... Granger, C. B. (2014). Response to letter regarding article, "efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation". Circulation, 129(2), e21-e22. https://doi.org/10.1161/CIRCULATIONAHA.113.005709